Quarterly report pursuant to Section 13 or 15(d)

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)

v3.10.0.1
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Dec. 31, 2017
Net loss $ 3,294,973 $ (589,983) $ 7,100,217 $ (5,366,946)  
Cash flows from operations     9,925,819 647,216  
Asset impairment charges 0 0 0 0  
Cash equivalents 0   0   $ 0
Restricted cash 738,356   738,356   778,579
Cash in excess of FDIC limits 10,027,090   10,027,090    
Allowance for doubtful accounts 200,000   200,000   200,000
Bad debt expense     46,779 400,435  
Shipping and handling charged to customers 490,881 265,685 1,297,844 589,687  
Allowance for customer returns 0   0   0
Inventory, noncurrent 803,100   803,100   5,667,101
Depreciation expense 121,911 30,897 349,121 117,744  
Research and development 529,562 179,338 1,125,270 573,701  
Advertising expense 231,715 152,687 634,274 261,462  
Unrecognized tax benefits 0   0   $ 0
Former Credit Card Processor [Member]          
Bad debt expense 40,223        
Consumer Products [Member]          
Research and development 170,466 76,520 362,933 181,509  
Specialty Pharmaceuticals [Member]          
Research and development 359,096 $ 102,818 $ 762,337 $ 392,192  
OptionsMember          
Antidilutive shares outstanding     19,562,475    
Warrants [Member]          
Antidilutive shares outstanding     79,891    
Performance based stock options [Member]          
Stock that may be required to issue     10,750,000    
Germany and The Netherlands [Member]          
Inventory, noncurrent $ 312,626   $ 312,626